The role of the endocannabinoid system and the CB1 receptor in depression and anxiety is also supported by several lines of animal studies linking reduced CB1 signaling to increased depression and anxiety (Hill and Gorzalka, 2005). This evidence concerns the gene CNR1 and depressive disorder.